Treatment of Non-small Cell Lung Cancer With PD-1 Monoclonal Antibody Combined With Donafenib Toluene Sulfonate
Condition: Non-small Cell Lung Cancer Intervention: Drug: donafenib tablets Sponsor: First Affiliated Hospital of Zhejiang University Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials